Stuart has an exceptional track record in fundraising in the UK markets, with board-level experience in both private and public medical companies.
His key achievements include the creation of Sphere Medical, which ultimately he floated on the AIM in the most challenging markets. He attracted global players such as Johnson & Johnson and developed the company to the point of marketing its breakthrough product, Proxima, worldwide. His current area of interest is technology convergence, particularly in the monitoring and diagnostics applications.
He was previously Head of Life Sciences at Scientific Generics Plc (now Sagentia Plc), and before that worked for Powderject Pharmaceuticals Plc, Diametrics Inc and Pfizer Inc.
BACKSpeak with us about our pharma & biotech consulting services.
Alacrita, UK, Europe & Asia
2 Royal College St
London, UK
NW1 0NH
Registered in England & Wales.
No. 10530608
Alacrita, US
One Broadway
Floor 14
Cambridge, MA 02142
Registered in Massachusetts.
© 2009 - 2024 Alacrita Holdings Limited